Research programme: rheumatoid arthritis therapy - Deltagen
Alternative Names: Rheumatoid arthritis therapy research programme - DeltagenLatest Information Update: 08 Mar 2011
At a glance
- Originator Deltagen
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Rheumatoid arthritis
Most Recent Events
- 01 Jul 2003 Deltagen has filed a voluntary petition under Chapter 11 of the federal Bankruptcy Code
- 14 Oct 2002 Deltagen has discovered a new drug target for the potential treatment of rheumatoid arthritis
- 22 Jul 2002 Preclinical trials in Inflammation in USA (unspecified route)